Yifeng Pharmacy Chain Co., Ltd.
603939
Rang in aandelen
#3633
Yifeng Pharmacy Chain Co., Ltd. serves as a key distributor of pharmaceutical... Yifeng Pharmacy Chain Co., Ltd. serves as a key distributor of pharmaceutical goods across China. As of March 31, 2021, the company oversaw an expansive network of approximately 6,279 retail pharmacies. These establishments are strategically situated throughout various significant Chinese provinces and municipalities, including Hunan, Hubei, Shanghai, Jiangsu, Zhejiang, Jiangxi, Guangdong, Hebei, and Beijing. The firm was founded in 2001 and has its primary corporate office located in Changsha, China.
Aandeelprijs
$3.84
Marktkapitalisatie
$4.65B
Verandering (1 dag)
2.73%
Verandering (1 jaar)
8.86%
Land
CN
Handel Yifeng Pharmacy Chain Co., Ltd. (603939)
Categorie
Healthcare
Winst voor Yifeng Pharmacy Chain Co., Ltd. (603939)
Winst in Jun 2026 TTM: $381.79M
Volgens de meest recente financiële verslagen van Yifeng Pharmacy Chain Co., Ltd. bedraagt de huidige winst van het bedrijf $381.79M. In 2023 behaalde het bedrijf een winst van $287.85M, een stijging ten opzichte van de winst van 2022, die $272.18M bedroeg. De weergegeven winst op deze pagina is de winst vóór rente en belastingen, oftewel EBIT.
Winstgeschiedenis van Yifeng Pharmacy Chain Co., Ltd. van 2011 tot 2026
Winst aan het einde van elk jaar
| Jaar | Winst | Wijzigen |
|---|---|---|
| 2026 (TTM) | $381.79M | 27.69% |
| 2024 | $299.00M | 3.87% |
| 2023 | $287.85M | 5.76% |
| 2022 | $272.18M | 29.30% |
| 2021 | $210.50M | 21.98% |
| 2020 | $172.57M | 47.57% |
| 2019 | $116.94M | 38.39% |
| 2018 | $84.50M | 28.43% |
| 2017 | $65.80M | 49.37% |
| 2016 | $44.05M | 19.39% |
| 2015 | $36.90M | 19.46% |
| 2014 | $30.89M | 38.66% |
| 2013 | $22.28M | 49.09% |
| 2012 | $14.94M | 21.08% |
| 2011 | $12.34M | 0.00% |
Winst van vergelijkbare bedrijven of concurrenten
| Bedrijf | Winst | Winstverschil | Land |
|---|---|---|---|
| $1.35B | 253.57% |
US
|
|
| - | - |
SE
|
|
| - | - |
FR
|
|
| $26.37M | -93.09% |
US
|
|
| - | - |
IT
|